Representing Animals Foundation
15.5.2024 21:04:31 CEST | ACCESS Newswire | Press release
SOUTHAMPTON, ENGLAND / ACCESSWIRE / May 15, 2024 / A new study has increased confidence in the apparent benefits of vegan diets for dogs. The study reanalysed data within a key 2022 study of 2,536 dogs - the largest published study within this field. That study concluded that the healthiest and least hazardous dog foods were nutritionally-sound vegan diets. However, owner opinions of health were included, which may not always be reliable. For example, owners committed to feeding vegan or meat-based diets might sometimes fail to recognise or report subsequent health problems.
The new study used additional statistical methods, including machine learning, to analyse owner opinions of health. It found these were minimally affected when vegan diets were fed. Stated Prof. Andrew Knight - lead author of the original study, "I was relieved to see confirmation that feeding vegan diets had minimal impact on owner opinions about health. This increases my confidence in the reliability of the owner opinions we used."
The new study focused specifically on subjective owner opinions of health, in contrast to the original study which examined seven general indicators of illness, including more objective data such as the frequency of medication use, therapeutic diet use, and veterinary visits. The original study also analysed the reported assessments of veterinarians concerning dog health, as well the prevalence of 22 of the most common health disorders in dogs. Stated Knight, "The large number of health parameters we studied, and the very large number of dogs included, provide a high degree of confidence in the results."
By May 2024 there were 10 studies in dogs, and three in cats, demonstrating equivalent or superior health outcomes when vegan diets are fed, as well as one systematic review covering both species. In April 2024, the longest, most comprehensive peer-reviewed study demonstrated that dogs fed nutritionally-sound vegan diets maintained health outcomes as well as those fed meat. The study comprehensively analysed blood cells and biochemistry, blood nutrient levels, urine, veterinary clinical parameters, and monthly pet owner questionnaires. It studied 15 dogs fed solely vegan diets for an entire year - just under one tenth of an average dog lifespan, or around seven human years. Another 2022 study demonstrated that 1,052 dogs fed vegan diets lived 1.5 years longer, on average, than dogs fed meat. Stated Prof. Knight, "This equates to around an extra decade of life for a human. Additionally, dogs fed vegan diets appear less impacted by certain health problems that impair quality of life. However, it is essential that any diets fed be nutritionally-sound."
Prof. Knight also analysed the environmental benefits of vegan pet diets in a major recent study. This demonstrated that if all the world's pet dogs went vegan, more greenhouse gases than those emitted by the UK would be saved. Knight stated that "Climate change is becoming a major threat to life on Earth. With the livestock sector a leading cause, substantial dietary change is now essential, and that includes pet diets."
Contact Information
Andrew Knight
Veterinary Professor of Animal Welfare
andrew.knight@winchester.ac.uk
SOURCE: Prof. Andrew Knight
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
LiberNovo Previews Treat Yourself Halloween Flash Sale Across Europe29.10.2026 08:40:00 CET | Press release
HONG KONG, HK / ACCESS Newswire / October 29, 2026 / LiberNovo is bringing Halloween treats to the desk with its Treat Yourself Halloween Flash Sale, opening October 29 across the European Union and United Kingdom. The event pairs savings of up to 40% on selected Maxis and LiberNovo Omni Pro configurations with limited seasonal gifts for qualifying early shoppers. Spooky extras for your desk Limited Halloween-themed gift packs are available to the first 300 eligible customers in the European Union and the first 100 in the United Kingdom, on a first-come, first-served basis while supplies last. Gift contents, qualifying purchases and availability follow the terms on each regional campaign page. More room for Big and Tall users Maxis is designed around larger frames, with a wider seat and 52 cm seat depth for greater thigh support and room to shift naturally. Maxis Manual provides adjustment by hand. Maxis Electric adds motorised lumbar adjustment and OmniStretch guided back stretching.
IAVI Awarded $36 Million From BARDA for Bundibugyo Virus Vaccine Development28.10.2026 16:50:00 CET | Press release
NEW YORK, NY, SINGAPORE, SG INCHEON, SOUTH KOREA, AND DESSAU-ROSSLAU, DE / ACCESS Newswire / October 28, 2026 / Today IAVI, a global nonprofit biomedical research organization, together with partners Hilleman Laboratories, SK bioscience, and IDT Biologika announced that IAVI has been awarded US $36 million of a contract valued up to US $99 million from the Administration for Strategic Preparedness and Response (ASPR); Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services, to advance development, manufacturing, and clinical evaluation of its one-dose vaccine candidate against Bundibugyo virus (BDBV), the cause of the ongoing Ebola epidemic in the Democratic Republic of the Congo (DRC). The award supports manufacturing of vaccine doses for clinical evaluation and outbreak response, clinical and regulatory activities including a Phase 1 trial, and options for expanded manufacturing to support future preparedness needs, as
GA-ASI and Saab Perform Advanced AEW Flight Testing on Uncrewed MQ-9B28.10.2026 16:00:00 CET | Press release
SAN DIEGO, CA / ACCESS Newswire / October 28, 2026 / General Atomics Aeronautical Systems, Inc. (GA-ASI) has partnered with Saab to perform advanced flight testing of an Airborne Early Warning (AEW) system on an Uncrewed Aircraft System (UAS). The flight testing was conducted over the past few months using a GA-ASI-produced MQ-9B carrying a Saab LoyalEye radar operating from GA-ASI's Desert Horizon flight operations facility in Southern California. The flight test demonstrated simultaneous tracking of several airborne and maritime targets at long ranges. The airborne targets tracked included multiple instrumented red fighter jets and several commercial aircraft. MQ-9B is GA-ASI's flagship UAS, offering unmatched endurance, type certification and all-weather performance. GA-ASI is discussing unmanned AEW capabilities on MQ-9B with several customers. "This has been one of the most highly anticipated flight tests we have performed," said GA-ASI President David R. Alexander. "The level of
Juno Corp. Closes $25 Million Non-Brokered Private Placement28.10.2026 12:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / October 28, 2026 / Juno Corp. ("Juno" or the "Company"), the largest mineral claim holder and most active explorer in Ontario's Ring of Fire, is pleased to announce that it has completed a non-brokered private placement (the "Offering") for aggregate gross proceeds of $25,290,609. Pursuant to the Offering, the Company issued an aggregate of (i) 165,750 common shares of Juno ("HD Juno Shares"), on a non-flow-through basis at a price of $4.00 per HD Juno Share, (ii) 404,890 common shares of Juno that qualify as "flow-through shares" as defined in subsection 66(15) of the Income Tax Act (Canada) (the "Tax Act") (the "FT Juno Shares"), at a price of $4.50 per FT Juno Share, and (iii) 4,131,450 common shares of Juno, which qualify as "flow-through shares" as defined in subsection 66(15) of the Tax Act (the "Premium FT Juno Shares", and together with the HD Juno Shares and the FT Juno Shares, the "Juno Securities"), at a price of $5.52 per Premium FT Juno Shar
DistillerSR Launches Smart Chat, an AI Chat Interface Built Into Its Evidence Platform27.10.2026 15:55:00 CET | Press release
OTTAWA, ON / ACCESS Newswire / October 27, 2026 / DistillerSR® Inc., the pioneer and market leader in AI-enabled literature review automation and evidence management, today announced the launch of Smart Chat. Smart Chat brings DistillerSR's Agentic AI capabilities in-platform. Since September 2025, DistillerSR Agentic AI has eliminated evidence silos at customer organizations by connecting Large Language Models to a repository of expertly validated literature evidence. Smart Chat now makes that same capability available natively within DistillerSR's secure platform. "While researchers recognize the power of generative AI, many life sciences organizations cannot risk connecting external LLMs to their sensitive research data," said Peter O'Blenis, CEO of DistillerSR. "Smart Chat removes that barrier. It is built directly into the platform teams already use, works exclusively with their own DistillerSR projects, and is included with every version of DistillerSR." Smart Chat works only wit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
